Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366310 · ClinicalTrials.gov registry record
Capillary Refill Index with Rewarming
A clinical trial, sponsored by Nihon Kohden.
- Terminated
- Registry status
- 65
- Enrollment target
NCT04366310: Clinical Trial study, sponsored by Nihon Kohden.
NCT04366310 is a clinical trial that was terminated before completion, run by Nihon Kohden. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04366310 was terminated before completion, sponsored by Nihon Kohden.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
A new technology, capillary refill index (CRI) can be useful for assessing peripheral perfusion status quantitatively, but this value can be influenced by fingertip temperature. The aim of this study is to evaluate the predictive accuracy of CRI after a temperature control (warming) procedure in predicting 30-day mortality among ICU/CCU patients. The investigators hypothesized that lowered fingertip temperature can lead prolonged CRI values which are considered as false positives in detection of high-risk patients for mortality, because it causes poor peripheral perfusion which does not reflect hemodynamic instability. The investigators will use the warming procedure to remove or reduce the effect of the fingertip temperature on the CRI measurement and will analyze whether it contributes to reduction of false positives in detection of high-risk patients for mortality.
Primary Outcome
Receiver operator characteristic (ROC) curve analysis of CRI after the temperature control procedure for 30 days mortality of ICU patients will be performed and area under the curve (AUC) will be calculated.
Interventions
- DEVICE capillary refill index
- PROCEDURE rewarming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2023-03-01 |
Why NCT04366310 stopped before completion
NCT04366310 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which capillary refill index is the first listed.
NCT04366310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04366310 about?
NCT04366310 is a clinical study titled "Capillary Refill Index with Rewarming". A new technology, capillary refill index (CRI) can be useful for assessing peripheral perfusion status quantitatively, but this value can be influenced by fingertip temperature. The aim of this study is to evaluate the predictive accuracy of CRI after a temperature control (warming) procedure in pre...
What is the current status of trial NCT04366310?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 2020-11-16. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT04366310?
The interventions under investigation include: capillary refill index (DEVICE), rewarming (PROCEDURE).
Who is sponsoring clinical trial NCT04366310?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI